Cargando…
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing between Two Centres
Amyloidosis is a relatively rare human disease caused by the deposition of abnormal protein fibres in the extracellular space of various tissues, impairing their normal function. Proteomic analysis of patients’ biopsies, developed by Dogan and colleagues at the Mayo Clinic, has become crucial for cl...
Autores principales: | Canetti, Diana, Brambilla, Francesca, Rendell, Nigel B., Nocerino, Paola, Gilbertson, Janet A., Di Silvestre, Dario, Bergamaschi, Andrea, Lavatelli, Francesca, Merlini, Giampaolo, Gillmore, Julian D., Bellotti, Vittorio, Mauri, Pierluigi, Taylor, Graham W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037974/ https://www.ncbi.nlm.nih.gov/pubmed/33805439 http://dx.doi.org/10.3390/molecules26071913 |
Ejemplares similares
-
Lysozyme amyloid: evidence for the W64R variant by proteomics in the absence of the wild type protein
por: Moura, Alexandra, et al.
Publicado: (2020) -
The Protein Network in Subcutaneous Fat Biopsies from Patients with AL Amyloidosis: More Than Diagnosis?
por: Di Silvestre, Dario, et al.
Publicado: (2023) -
Clinical ApoA‐IV amyloid is associated with fibrillogenic signal sequence
por: Canetti, Diana, et al.
Publicado: (2021) -
Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient
por: Swuec, Paolo, et al.
Publicado: (2019) -
Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsies
por: Mangione, P. Patrizia, et al.
Publicado: (2017)